MiR‐191‐5p inhibits lung adenocarcinoma by repressing SATB1 to inhibit Wnt pathway

miR-150-5p Inhibits Non-Small-Cell Lung Cancer Metastasis and Recurrence by Targeting HMGA2 and β-Catenin Signaling

(2019) Fu-Qiang Dai et al.   Molecular Therapy-Nucleic Acids

MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma

(2017) Hao Li et al.   HEPATOLOGY

Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database

(2017) Shenhai Wei et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

(2017) Rajesha Rupaimoole et al.   NATURE REVIEWS DRUG DISCOVERY

Wnt signaling in cancer

(2016) T Zhan et al.   ONCOGENE

Inhibition of miR-191 contributes to radiation-resistance of two lung cancer cell lines by altering autophagy activity

(2015) Zhenkuan Liu et al.   Cancer Cell International

The Role of miR-21 in Cancer

(2015) Susan R. Pfeffer et al.   DRUG DEVELOPMENT RESEARCH

miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ

(2015) Xiao-Fei Zhang et al.   Oncotarget

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma

(2014) Jacob Elebro et al.   Journal of Translational Medicine

DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification

(2013) C. Vanesa Díaz-García et al.   CARCINOGENESIS

Genetics and biomarkers in personalisation of lung cancer treatment

(2013) Rafael Rosell et al.   LANCET

Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue

(2012) Fermín MAR-AGUILAR et al.   Asia-Pacific Journal of Clinical Oncology

Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer

(2012) Björn Nodin et al.   Diagnostic Pathology

Genome organizing function of SATB1 in tumor progression

(2012) Terumi Kohwi-Shigematsu et al.   SEMINARS IN CANCER BIOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Loss of Special AT-Rich Binding Protein 1 Expression is a Marker of Poor Survival in Lung Cancer

(2011) Christina I. Selinger et al.   Journal of Thoracic Oncology

Non-small-cell lung cancer

(2011) Peter Goldstraw et al.   LANCET

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

(2010) M-P Puisségur et al.   CELL DEATH AND DIFFERENTIATION

Wnt/ -Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy

(2010) L. Gattinoni et al.   CLINICAL CANCER RESEARCH

Overexpression of MicroRNA miR-30a or miR-191 in A549 Lung Cancer or BEAS-2B Normal Lung Cell Lines Does Not Alter Phenotype

(2010) Santosh Kumar Patnaik et al.   PLoS One

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

(2009) L. Dyrskjot et al.   CANCER RESEARCH